Shedding of soluble platelet-derived growth factor receptor-β from human brain pericytes

Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis

Kayed, R., Head, E., Thompson, J. L., McIntire, T. M., Milton, S. C., Cotman, C. W., & Glabe, C. G. (2003) · Science · doi:10.1126/science.1079469 · Cited by 4,064 · see citing works

Neurovascular pathways to neurodegeneration in Alzheimer’s disease and other disorders

Zlokovic, B. V. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn3114 · Cited by 2,969 · see citing works

Pericytes regulate the blood–brain barrier

Armulik, A., Genové, G., Mäe, M., Nisancioglu, M. H., Wallgard, E., Niaudet, C., He, L., Norlin, J., Lindblom, P., Strittmatter, K., et al. (2010) · Nature · doi:10.1038/nature09522 · Cited by 2,843 · see citing works

Pericytes: Developmental, Physiological, and Pathological Perspectives, Problems, and Promises

Armulik, A., Genové, G., & Betsholtz, C. (2011) · Developmental Cell · doi:10.1016/j.devcel.2011.07.001 · Cited by 2,653 · see citing works

Pericyte Loss and Microaneurysm Formation in PDGF-B-Deficient Mice

Lindahl, P., Johansson, B. R., Levéen, P., & Betsholtz, C. (1997) · Science · doi:10.1126/science.277.5323.242 · Cited by 2,226 · see citing works

Pericytes are required for blood–brain barrier integrity during embryogenesis

Daneman, R., Zhou, L., Kebede, A. A., & Barres, B. A. (2010) · Nature · doi:10.1038/nature09513 · Cited by 2,128 · see citing works

Blood-brain barrier breakdown in the aging human hippocampus

Montagne, A., Barnes, S. R., Sweeney, M. D., Halliday, M. R., Sagare, A. P., Zhao, Z., Toga, A. W., Jacobs, R. E., Liu, C. Y., Amezcua, L., et al. (2015) · Neuron · doi:10.1016/j.neuron.2014.12.032 · Cited by 2,102 · see citing works

The Pathobiology of Vascular Dementia

Iadecola, C. (2013) · Neuron · doi:10.1016/j.neuron.2013.10.008 · Cited by 1,857 · see citing works

Role of PDGF-B and PDGFR-β in recruitment of vascular smooth muscle cells and pericytes during embryonic blood vessel formation in the mouse

Hellström, M., Kalén, M., Lindahl, P., Abramsson, A., & Betsholtz, C. (1999) · Development · doi:10.1242/dev.126.14.3047 · Cited by 1,702 · see citing works

Pericytes Control Key Neurovascular Functions and Neuronal Phenotype in the Adult Brain and during Brain Aging

Bell, R. D., Winkler, E. A., Sagare, A. P., Singh, I., LaRue, B., Deane, R., & Zlokovic, B. V. (2010) · Neuron · doi:10.1016/j.neuron.2010.09.043 · Cited by 1,448 · see citing works

Cerebral microvascular pathology in aging and Alzheimer's disease

Farkas, E., & Luiten, P. G. M. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(00)00068-x · Cited by 1,102 · see citing works

Central nervous system pericytes in health and disease

Winkler, E. A., Bell, R. D., & Zlokovic, B. V. (2011) · Nature Neuroscience · doi:10.1038/nn.2946 · Cited by 962 · see citing works

apoE isoform–specific disruption of amyloid β peptide clearance from mouse brain

Deane, R., Sagare, A., Hamm, K., Parisi, M., Lane, S., Finn, M. B., Holtzman, D. M., & Zlokovic, B. V. (2008) · Journal of Clinical Investigation · doi:10.1172/jci36663 · Cited by 771 · see citing works

Accelerated pericyte degeneration and blood–brain barrier breakdown in apolipoprotein E4 carriers with Alzheimer’s disease

Halliday, M. R., Rege, S. V., Ma, Q., Zhao, Z., Miller, C. A., Winkler, E. A., & Zlokovic, B. V. (2016) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2015.44 · Cited by 649 · see citing works

Deficiency in Mural Vascular Cells Coincides with Blood–Brain Barrier Disruption in <scp>A</scp> lzheimer's Disease

Sengillo, J. D., Winkler, E. A., Walker, C. T., Sullivan, J. S., Johnson, M., & Zlokovic, B. V. (2013) · Brain Pathology · doi:10.1111/bpa.12004 · Cited by 553 · see citing works

Activation of PKC-δ and SHP-1 by hyperglycemia causes vascular cell apoptosis and diabetic retinopathy

Geraldes, P., Hiraoka‐Yamamoto, J., Matsumoto, M., Clermont, A. C., Leitges, M., Marette, A., Aiello, L. P., Kern, T. S., & King, G. L. (2009) · Nature Medicine · doi:10.1038/nm.2052 · Cited by 424 · see citing works

Blood–spinal cord barrier breakdown and pericyte reductions in amyotrophic lateral sclerosis

Winkler, E. A., Sengillo, J. D., Sullivan, J. S., Henkel, J. S., Appel, S. H., & Zlokovic, B. V. (2013) · Acta Neuropathologica · doi:10.1007/s00401-012-1039-8 · Cited by 354 · see citing works

Pericyte-specific expression of PDGF beta receptor in mouse models with normal and deficient PDGF beta receptor signaling

Winkler, E. A., Bell, R. D., & Zloković, B. V. (2010) · Molecular Neurodegeneration · doi:10.1186/1750-1326-5-32 · Cited by 346 · see citing works

Role of the MEOX2 homeobox gene in neurovascular dysfunction in Alzheimer disease

Wu, Z., Guo, H., Chow, N., Sallstrom, J., Bell, R. D., Deane, R., Brooks, A. I., Kanagala, S., Rubio, A., Sagare, A., et al. (2005) · Nature Medicine · doi:10.1038/nm1287 · Cited by 280 · see citing works

SRF and myocardin regulate LRP-mediated amyloid-β clearance in brain vascular cells

Bell, R. D., Deane, R., Chow, N., Long, X., Sagare, A., Singh, I., Streb, J. W., Guo, H., Rubio, A., Van Nostrand, W., et al. (2009) · Nature Cell Biology · doi:10.1038/ncb1819 · Cited by 261 · see citing works

Human blood-brain barrier receptors for Alzheimer's amyloid-beta 1- 40. Asymmetrical binding, endocytosis, and transcytosis at the apical side of brain microvascular endothelial cell monolayer.

Mackic, J. B., Stins, M., McComb, J. G., Calero, M., Ghiso, J., Kim, K. S., Yan, S. D., Stern, D., Schmidt, A. M., Frangione, B., et al. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2029 · Cited by 242 · see citing works

Blood–Spinal Cord Barrier Pericyte Reductions Contribute to Increased Capillary Permeability

Winkler, E. A., Sengillo, J. D., Bell, R. D., Wang, J., & Zlokovic, B. V. (2012) · Journal of Cerebral Blood Flow &amp; Metabolism · doi:10.1038/jcbfm.2012.113 · Cited by 226 · see citing works

Serum response factor and myocardin mediate arterial hypercontractility and cerebral blood flow dysregulation in Alzheimer's phenotype

Chow, N., Bell, R. D., Deane, R., Streb, J. W., Chen, J., Brooks, A., Van Nostrand, W., Miano, J. M., & Zlokovic, B. V. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608251104 · Cited by 209 · see citing works

Additive Effects of PDGF Receptor β Signaling Pathways in Vascular Smooth Muscle Cell Development

Tallquist, M. D., French, W. J., & Soriano, P. (2003) · PLoS Biology · doi:10.1371/journal.pbio.0000052 · Cited by 192 · see citing works

Induction of alpha-smooth muscle actin expression in cultured human brain pericytes by transforming growth factor-beta 1.

Verbeek, M. M., Otte‐Höller, I., Wesseling, P., Ruiter, D. J., & de Waal, R. M. W. (1994) · PubMed Central · Cited by 187 · see citing works

Pericytes are involved in the pathogenesis of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy

Ghosh, M., Balbi, M., Hellal, F., Dichgans, M., Lindauer, U., & Plesnila, N. (2015) · Annals of Neurology · doi:10.1002/ana.24512 · Cited by 171 · see citing works

The complex mural cell: Pericyte function in health and disease

Dijk, C. V., Nieuweboer, F. E., Pei, J. Y., Xu, Y. J., Bürgisser, P. E., van Mulligen, E., el Azzouzi, H., Duncker, D. J., Verhaar, M. C., & Cheng, C. (2015) · International Journal of Cardiology · doi:10.1016/j.ijcard.2015.03.258 · Cited by 154 · see citing works

Review of the Pericyte during Angiogenesis and its Role in Cancer and Diabetic Retinopathy

Hall, A. P. (2006) · Toxicologic Pathology · doi:10.1080/01926230600936290 · Cited by 141 · see citing works

Elevated CSF levels of TACE activity and soluble TNF receptors in subjects with mild cognitive impairment and patients with Alzheimer's disease

Jiang, H., Hampel, H., Prvulovic, D., Wallin, A., Blennow, K., Li, R., & Shen, Y. (2011) · Molecular Neurodegeneration · doi:10.1186/1750-1326-6-69 · Cited by 99 · see citing works

The molecular, cellular, and morphological components of blood–brain barrier development during embryogenesis

Hagan, N., & Ben‐Zvi, A. (2014) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2014.12.006 · Cited by 66 · see citing works

Amyloid β-Protein Stimulates the Expression of Urokinase-type Plasminogen Activator (uPA) and Its Receptor (uPAR) in Human Cerebrovascular Smooth Muscle Cells

Davis, J., Wagner, M. R., Zhang, W., Xu, F., & Nostrand, W. E. V. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301398200 · Cited by 60 · see citing works

Stimulation of Platelet-derived Growth Factor Receptor β (PDGFRβ) Activates ADAM17 and Promotes Metalloproteinase-dependent Cross-talk between the PDGFRβ and Epidermal Growth Factor Receptor (EGFR) Signaling Pathways

Mendelson, K., Swendeman, S. L., Säftig, P., & Blobel, C. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.102566 · Cited by 53 · see citing works

Amyloid β-protein precursor in cultured leptomeningeal smooth muscle cells

Nostrand, W. E. V., Rozemüller, A. J. M., Chung, R. T., Cotman, C. W., & Saporito-Irwin, S. M. (1994) · Amyloid · doi:10.3109/13506129409148618 · Cited by 47 · see citing works

PDGFRβ+ cells in human and experimental neuro-vascular dysplasia and seizures

Garbelli, R., de Bock, F., Medici, V., Rousset, M.-C., Villani, F. S., Boussadia, B., Arango-Lievano, M., Jeanneteau, F. D., Daneman, R., Bartoloméi, F., et al. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.07.090 · Cited by 44 · see citing works

Blood–brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders

Sweeney, M. D., Sagare, A. P., & Zlokovic, B. V. (2018) · Nature Reviews Neurology · doi:10.1038/nrneurol.2017.188 · Cited by 3,076 · see citing works

Blood–brain barrier breakdown is an early biomarker of human cognitive dysfunction

Nation, D. A., Sweeney, M. D., Montagne, A., Sagare, A. P., D’Orazio, L. M., Pachicano, M., Sepehrband, F., Nelson, A. R., Buennagel, D. P., Harrington, M. G., et al. (2019) · Nature Medicine · doi:10.1038/s41591-018-0297-y · Cited by 1,728 · see citing works

APOE4 leads to blood–brain barrier dysfunction predicting cognitive decline

Montagne, A., Nation, D. A., Sagare, A. P., Barisano, G., Sweeney, M. D., Chakhoyan, A., Pachicano, M., Joe, E., Nelson, A. R., D’Orazio, L. M., et al. (2020) · Nature · doi:10.1038/s41586-020-2247-3 · Cited by 1,281 · see citing works

Pericytes of the neurovascular unit: key functions and signaling pathways

Sweeney, M. D., Ayyadurai, S., & Zlokovic, B. V. (2016) · Nature Neuroscience · doi:10.1038/nn.4288 · Cited by 1,125 · see citing works

The blood–brain barrier in systemic infection and inflammation

Galea, I. (2021) · Cellular and Molecular Immunology · doi:10.1038/s41423-021-00757-x · Cited by 764 · see citing works

Vascular dysfunction—The disregarded partner of Alzheimer's disease

Sweeney, M. D., Montagne, A., Sagare, A. P., Nation, D. A., Schneider, L. S., Chui, H. C., Harrington, M. G., Pa, J., Law, M., Wang, D. J. J., et al. (2019) · Alzheimer's &amp; Dementia · doi:10.1016/j.jalz.2018.07.222 · Cited by 711 · see citing works

Neurovascular dysfunction and neurodegeneration in dementia and Alzheimer's disease

Nelson, A. R., Sweeney, M. D., Sagare, A. P., & Zlokovic, B. V. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.12.016 · Cited by 559 · see citing works

Pericyte loss leads to circulatory failure and pleiotrophin depletion causing neuron loss

Nikolakopoulou, A. M., Montagne, A., Kisler, K., Dai, Z., Wang, Y., Huuskonen, M. T., Sagare, A. P., Lazić, D., Sweeney, M. D., Kong, P., et al. (2019) · Nature Neuroscience · doi:10.1038/s41593-019-0434-z · Cited by 382 · see citing works

Brain Pericytes As Mediators of Neuroinflammation

Rustenhoven, J., Jansson, D., Smyth, L. C., & Dragunow, M. (2017) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2016.12.001 · Cited by 371 · see citing works

Blood–Brain Barrier Breakdown: An Emerging Biomarker of Cognitive Impairment in Normal Aging and Dementia

Hussain, B., Fang, C., & Chang, J. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.688090 · Cited by 251 · see citing works

Targeting pericytes for therapeutic approaches to neurological disorders

Cheng, J., Korte, N., Nortley, R., Sethi, H., Tang, Y., & Attwell, D. (2018) · Acta Neuropathologica · doi:10.1007/s00401-018-1893-0 · Cited by 242 · see citing works

Differing associations between Aβ accumulation, hypoperfusion, blood–brain barrier dysfunction and loss of PDGFRB pericyte marker in the precuneus and parietal white matter in Alzheimer's disease

Miners, J. S., Schulz, I., & Love, S. (2018) · Journal of Cerebral Blood Flow &amp; Metabolism · doi:10.1177/0271678x17690761 · Cited by 208 · see citing works

Single-Cell Analysis of Blood-Brain Barrier Response to Pericyte Loss

Mäe, M. A., He, L., Nordling, S., Vázquez-Liébanas, E., Nahar, K., Jung, B., Li, X., Tan, B. C., Foo, J. C., Cazenave‐Gassiot, A., et al. (2020) · Circulation Research · doi:10.1161/circresaha.120.317473 · Cited by 203 · see citing works

Age-Associated Changes in the Immune System and Blood–Brain Barrier Functions

Erickson, M. A., & Banks, W. A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20071632 · Cited by 192 · see citing works

Emerging roles for CNS fibroblasts in health, injury and disease

Dorrier, C., Jones, H. E., Pintarić, L., Siegenthaler, J. A., & Daneman, R. (2021) · Nature reviews. Neuroscience · doi:10.1038/s41583-021-00525-w · Cited by 194 · see citing works

Cerebral Microvascular Injury: A Potentially Treatable Endophenotype of Traumatic Brain Injury-Induced Neurodegeneration

Sandsmark, D. K., Bashir, A., Wellington, C. L., & Diaz-Arrastia, R. R. (2019) · Neuron · doi:10.1016/j.neuron.2019.06.002 · Cited by 178 · see citing works

Molecular biomarkers for vascular cognitive impairment and dementia

Hosoki, S., Hansra, G. K., Jayasena, T., Poljak, A., Mather, K. A., Catts, V. S., Rust, R., Sagare, A. P., Kovacic, J. C., Brodtmann, A. G., et al. (2023) · Nature Reviews Neurology · doi:10.1038/s41582-023-00884-1 · Cited by 166 · see citing works

Cerebrovascular pathology during the progression of experimental Alzheimer's disease

Giannoni, P., Arango-Lievano, M., das Neves, I., Rousset, M.-C., Baranger, K., Rivera, S., Jeanneteau, F. D., Claeysen, S., & Marchi, N. (2016) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.01.001 · Cited by 146 · see citing works

CSF evidence of pericyte damage in Alzheimer’s disease is associated with markers of blood-brain barrier dysfunction and disease pathology

Miners, J. S., Kehoe, P. G., Love, S., Zetterberg, H., & Blennow, K. (2019) · Alzheimer s Research & Therapy · doi:10.1186/s13195-019-0534-8 · Cited by 137 · see citing works

PDGF/PDGFR axis in the neural systems

Sil, S., Periyasamy, P., Thangaraj, A., Chivero, E. T., & Buch, S. J. (2018) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2018.01.006 · Cited by 131 · see citing works

Characterisation of PDGF-BB:PDGFRβ signalling pathways in human brain pericytes: evidence of disruption in Alzheimer’s disease

Smyth, L. C. D., Highet, B., Jansson, D., Wu, J., Rustenhoven, J., Aalderink, M., Tan, A. Y. S., Li, S., Johnson, R. H., Coppieters, N., et al. (2022) · Communications Biology · doi:10.1038/s42003-022-03180-8 · Cited by 118 · see citing works

Blood-brain barrier dysfunction and Alzheimer’s disease: associations, pathogenic mechanisms, and therapeutic potential

Chen, Y., He, Y., Han, J., Wei, W., & Chen, F. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1258640 · Cited by 116 · see citing works

Monomeric α-synuclein induces blood–brain barrier dysfunction through activated brain pericytes releasing inflammatory mediators in vitro

Dohgu, S., Takata, F., Matsumoto, J., Kimura, I., Yamauchi, A., & Kataoka, Y. (2019) · Microvascular Research · doi:10.1016/j.mvr.2019.03.005 · Cited by 112 · see citing works

Targeting pericytes for neurovascular regeneration

Geranmayeh, M. H., Rahbarghazi‬, R., & Farhoudi, M. (2019) · Cell Communication and Signaling · doi:10.1186/s12964-019-0340-8 · Cited by 105 · see citing works

The blood–brain barrier: a help and a hindrance

Rust, R., Yin, H. R., Buil, B. A., Sagare, A. P., & Kisler, K. (2025) · Brain · doi:10.1093/brain/awaf068 · Cited by 102 · see citing works

Linking peripheral atherosclerosis to blood–brain barrier disruption: elucidating its role as a manifestation of cerebral small vessel disease in vascular cognitive impairment

Nyúl‐Tóth, Á., Patai, R., Csiszár, A., Ungvari, A., Gulej, R., Mukli, P., Yabluchanskiy, A., Benyó, Z., Sótonyi, P., Prodan, C. I., et al. (2024) · GeroScience · doi:10.1007/s11357-024-01194-0 · Cited by 91 · see citing works

Brain injury-induced dysfunction of the blood brain barrier as a risk for dementia

Abrahamson, E. E., & Ikonomović, M. D. (2020) · Experimental Neurology · doi:10.1016/j.expneurol.2020.113257 · Cited by 87 · see citing works

Cerebrospinal Fluid/Plasma Albumin Ratio as a Biomarker for Blood-Brain Barrier Impairment Across Neurodegenerative Dementias

Musaeus, C. S., Gleerup, H. S., Høgh, P., Waldemar, G., Hasselbalch, S. G., & Simonsen, A. H. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200168 · Cited by 85 · see citing works

The pericyte–glia interface at the blood–brain barrier

Giannoni, P., Badaut, J., Dargazanli, C., De Maudave, A. F., Klement, W., Costalat, V., & Marchi, N. (2018) · Clinical Science · doi:10.1042/cs20171634 · Cited by 81 · see citing works

Excess vascular endothelial growth factor-A disrupts pericyte recruitment during blood vessel formation

Darden, J. A., Payne, L. B., Zhao, H., & Chappell, J. C. (2018) · Angiogenesis · doi:10.1007/s10456-018-9648-z · Cited by 80 · see citing works

Latest advances in cerebrospinal fluid and blood biomarkers of Alzheimer’s disease

Milà‐Alomà, M., Suárez‐Calvet, M., & Molinuevo, J. L. (2019) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756286419888819 · Cited by 78 · see citing works

Systemic infection exacerbates cerebrovascular dysfunction in Alzheimer’s disease

Asby, D. J., Boche, D., Allan, S. M., Love, S., & Miners, J. S. (2021) · Brain · doi:10.1093/brain/awab094 · Cited by 79 · see citing works

Pericytes and the Control of Blood Flow in Brain and Heart

Longden, T. A., Zhao, G., Hariharan, A., & Lederer, W. J. (2023) · Annual Review of Physiology · doi:10.1146/annurev-physiol-031522-034807 · Cited by 78 · see citing works

The microcirculation, the blood-brain barrier, and the neurovascular unit in health and Alzheimer disease: The aberrant pericyte is a central player

Divecha, Y. A., Rampes, S., Tromp, S., Boyanova, S., Fleckney, A. L., Fidanboylu, M., & Thomas, S. A. (2025) · Pharmacological Reviews · doi:10.1016/j.pharmr.2025.100052 · Cited by 79 · see citing works

A novel sensitive assay for detection of a biomarker of pericyte injury in cerebrospinal fluid

Sweeney, M. D., Sagare, A. P., Pachicano, M., Harrington, M. G., Joe, E., Chui, H. C., Schneider, L. S. S., Montagne, A., Ringman, J. M., Fagan, A. M., et al. (2020) · Alzheimer s & Dementia · doi:10.1002/alz.12061 · Cited by 74 · see citing works

Dynamic changes of CSF sPDGFRβ during ageing and AD progression and associations with CSF ATN biomarkers

Wang, J., Fan, D., Li, H.-Y., He, C.-Y., Shen, Y., Zeng, G., Chen, D., Yi, X., Ma, Y., Yu, J., et al. (2022) · Molecular Neurodegeneration · doi:10.1186/s13024-021-00512-w · Cited by 76 · see citing works

Significance of Blood and Cerebrospinal Fluid Biomarkers for Alzheimer’s Disease: Sensitivity, Specificity and Potential for Clinical Use

d’Abramo, C., D'adamio, L., & Giliberto, L. (2020) · Journal of Personalized Medicine · doi:10.3390/jpm10030116 · Cited by 68 · see citing works

Addressing Blood–Brain Barrier Impairment in Alzheimer’s Disease

Sharma, C., Woo, H., & Kim, S. R. (2022) · Biomedicines · doi:10.3390/biomedicines10040742 · Cited by 69 · see citing works

The pericyte microenvironment during vascular development

Payne, L. B., Zhao, H., James, C. C., Darden, J. A., McGuire, D. R., Taylor, S., Smyth, J. W., & Chappell, J. C. (2019) · Microcirculation · doi:10.1111/micc.12554 · Cited by 65 · see citing works

Assessing blood-brain barrier dysfunction and its association with Alzheimer’s pathology, cognitive impairment and neuroinflammation

Preis, L., Villringer, K., Brosseron, F., Düzel, E., Jessen, F., Petzold, G. C., Ramı́rez, A., Spottke, A. E., Fiebach, J. B., & Peters, O. (2024) · Alzheimer s Research & Therapy · doi:10.1186/s13195-024-01529-1 · Cited by 71 · see citing works

Impact of COVID‐19 on the Onset and Progression of Alzheimer's Disease and Related Dementias: A Roadmap for Future Research

Gordon, M. N., Heneka, M. T., Page, L. M. L., Limberger, C., Morgan, D., Tenner, A. J., Terrando, N., Willette, A. A., & Willette, S. A. (2021) · Alzheimer s & Dementia · doi:10.1002/alz.12488 · Cited by 59 · see citing works

Cancer Chemotherapy Related Cognitive Impairment and the Impact of the Alzheimer’s Disease Risk Factor APOE

Fernandez, H. R., Varma, A., Flowers, S. A., & Rebeck, G. W. (2020) · Cancers · doi:10.3390/cancers12123842 · Cited by 62 · see citing works

The Active Role of Pericytes During Neuroinflammation in the Adult Brain

Medina‐Flores, F., Hurtado‐Alvarado, G., Deli, M. A., & Gómez‐González, B. (2022) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-022-01208-5 · Cited by 60 · see citing works

Reciprocal Interaction Between Pericytes and Macrophage in Poststroke Tissue Repair and Functional Recovery

Shibahara, T., Ago, T., Tachibana, M., Nakamura, K., Yamanaka, K., Kuroda, J., Wakisaka, Y., & Kitazono, T. (2020) · Stroke · doi:10.1161/strokeaha.120.029827 · Cited by 58 · see citing works

The role of extracellular matrix alterations in mediating astrocyte damage and pericyte dysfunction in Alzheimer's disease: A comprehensive review

Anwar, M. M., Özkan, E., & Özdemir, Y. (2021) · European Journal of Neuroscience · doi:10.1111/ejn.15372 · Cited by 55 · see citing works

Associations of CSF PDGFRβ With Aging, Blood-Brain Barrier Damage, Neuroinflammation, and Alzheimer Disease Pathologic Changes

Cicognola, C., Mattsson, N., van Westen, D., Zetterberg, H., Blennow, K., Palmqvist, S., Ahmadi, K., Strandberg, O. T., Stomrud, E., Janelidze, S., et al. (2023) · Neurology · doi:10.1212/wnl.0000000000207358 · Cited by 52 · see citing works

The Complexity of Microglial Interactions With Innate and Adaptive Immune Cells in Alzheimer’s Disease

Wyatt-Johnson, S. K., & Brutkiewicz, R. R. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.592359 · Cited by 50 · see citing works

Nutritional metabolism and cerebral bioenergetics in Alzheimer's disease and related dementias

Yassine, H. N., Self, W. K., Kerman, B. E., Santoni, G., Shanmugam, N. K. N., Abdullah, L. I., Golden, L. R., Fonteh, A. N., Harrington, M. G., Gräff, J., et al. (2022) · Alzheimer s & Dementia · doi:10.1002/alz.12845 · Cited by 49 · see citing works

Blood Biomarkers for Evaluation of Perinatal Encephalopathy

Graham, E. M., Burd, I. D., Everett, A. D., & Northington, F. J. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00196 · Cited by 49 · see citing works

Pericytes Across the Lifetime in the Central Nervous System

Bennett, H. C., & Kim, Y. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.627291 · Cited by 47 · see citing works

Biomarkers of blood–brain barrier and neurovascular unit integrity in human cognitive impairment and dementia

French, S. R., Meyer, B. P., Arias, J. C., Levendovszky, S. R., & Weinkauf, C. C. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70104 · Cited by 45 · see citing works

Pericytes: Problems and Promises for CNS Repair

Laredo, F., Plebanski, J., & Tedeschi, A. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00546 · Cited by 44 · see citing works

Biomarkers Assessing Endothelial Dysfunction in Alzheimer’s Disease

Custodia, A., Aramburu-Núñez, M., Rodríguez‐Arrizabalaga, M., Peleteiro, J. M. P., Vázquez‐Vázquez, L., Camino-Castiñeiras, J., Aldrey, J. M., Castillo, J., Ouro, A., Sobrino, T., et al. (2023) · Cells · doi:10.3390/cells12060962 · Cited by 44 · see citing works

Elevated PDGF‐BB from Bone Impairs Hippocampal Vasculature by Inducing PDGFR β Shedding from Pericytes

Liu, G., Wang, J., Wei, Z., Fang, C., Shen, K., Cheng, Q., Qi, C., Li, T., Gao, P., Wong, P. C., et al. (2023) · Advanced Science · doi:10.1002/advs.202206938 · Cited by 42 · see citing works

Microvascular bioengineering: a focus on pericytes

Zhao, H., & Chappell, J. C. (2019) · Journal of Biological Engineering · doi:10.1186/s13036-019-0158-3 · Cited by 42 · see citing works

Identification and Validation of Aging-Related Genes in Alzheimer’s Disease

Zhang, Q., Li, J., & Weng, L. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.905722 · Cited by 41 · see citing works

Every-other-day feeding exacerbates inflammation and neuronal deficits in 5XFAD mouse model of Alzheimer's disease

Lazić, D., Tešić, V., Jovanović, M., Brkić, M., Milanović, D., Zloković, B. V., Kanazir, S., & Perović, M. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.104745 · Cited by 40 · see citing works

Undetectable gadolinium brain retention in individuals with an age‐dependent blood‐brain barrier breakdown in the hippocampus and mild cognitive impairment

Montagne, A., Huuskonen, M. T., Rajagopal, G., Sweeney, M. D., Nation, D. A., Sepehrband, F., D’Orazio, L. M., Harrington, M. G., Chui, H. C., Law, M., et al. (2019) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2019.07.012 · Cited by 33 · see citing works

Fluid biomarkers of the neurovascular unit in cerebrovascular disease and vascular cognitive disorders: A systematic review and meta-analysis

Hansra, G. K., Jayasena, T., Hosoki, S., Poljak, A., Lam, B. C. P., Rust, R., Sagare, A. P., Zloković, B. V., Thalamuthu, A., & Sachdev, P. S. (2024) · Cerebral Circulation - Cognition and Behavior · doi:10.1016/j.cccb.2024.100216 · Cited by 31 · see citing works

Engineering Brain-Specific Pericytes from Human Pluripotent Stem Cells

Jeske, R., Albo, J., Marzano, M., Bejoy, J., & Li, Y. (2020) · Tissue Engineering Part B Reviews · doi:10.1089/ten.teb.2020.0091 · Cited by 30 · see citing works

Dysautonomia and Implications for Anosmia in Long COVID-19 Disease

Vallée, A. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10235514 · Cited by 29 · see citing works

Neurochemical biomarkers to study CNS effects of COVID‐19: A narrative review and synthesis

Edén, A., Simrén, J., Price, R. W., Zetterberg, H., & Gisslén, M. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15459 · Cited by 28 · see citing works

SheddomeDB: the ectodomain shedding database for membrane-bound shed markers

Tien, W.-S., Chen, J., & Wu, K. (2017) · BMC Bioinformatics · doi:10.1186/s12859-017-1465-7 · Cited by 28 · see citing works

Phase 1 trial of ontuxizumab (MORAb‐004) in children with relapsed or refractory solid tumors: A report from the Children's Oncology Group Phase 1 Pilot Consortium (ADVL1213)

Norris, R. E., Fox, E., Reid, J. M., Ralya, A. T., Liu, X. W., Minard, C. G., & Weigel, B. J. (2018) · Pediatric Blood & Cancer · doi:10.1002/pbc.26944 · Cited by 27 · see citing works

Aging, vascular dysfunction, and the blood–brain barrier: unveiling the pathophysiology of stroke in older adults

Alaqel, S. I., Imran, M., Khan, A., & Nayeem, N. (2025) · Biogerontology · doi:10.1007/s10522-025-10209-y · Cited by 26 · see citing works

Impairment of cerebrovascular reactivity in response to hypercapnic challenge in a mouse model of repetitive mild traumatic brain injury

Lynch, C., Eisenbaum, M., Algamal, M., Balbi, M., Ferguson, S., Mouzon, B., Saltiel, N. A., Ojo, J. O., Diaz-Arrastia, R. R., Mullan, M., et al. (2020) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x20954015 · Cited by 25 · see citing works

The Blood–Brain Barrier: Much More Than a Selective Access to the Brain

Sánchez-Cano, F., Hernández‐Kelly, L. C., & Ortega, A. (2021) · Neurotoxicity Research · doi:10.1007/s12640-021-00431-0 · Cited by 27 · see citing works

Vascular-water-exchange MRI (VEXI) enables the detection of subtle AXR alterations in Alzheimer's disease without MRI contrast agent, which may relate to BBB integrity

Zhang, Y., Wang, Y., Li, Z., Wang, Z., Cheng, J., Bai, X., Hsu, Y., Sun, Y., Li, S., Shi, J., et al. (2023) · NeuroImage · doi:10.1016/j.neuroimage.2023.119951 · Cited by 26 · see citing works

Fibrin-targeting immunotherapy for dementia

Kantor, A. B., Akassoglou, K., & Stavenhagen, J. B. (2023) · The Journal of Prevention of Alzheimer's Disease · doi:10.14283/jpad.2023.105 · Cited by 24 · see citing works

Risk of cognitive decline progression is associated to increased blood‐brain‐barrier permeability: A longitudinal study in a memory unit clinical cohort

Puig‐Pijoan, A., Jiménez-Baladó, J., Fernández‐Lebrero, A., García‐Escobar, G., Navalpotro‐Gómez, I., Contador, J., Manero-Borràs, R. M., Puente, V., Suárez‐Pérez, A., Muñoz, F. J., et al. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.13433 · Cited by 22 · see citing works

Activation of spinal PDGFRβ in microglia promotes neuronal autophagy via p38 MAPK pathway in morphine‐tolerant rats

Jia, X., Zhang, A., Li, Z., Peng, X., Tian, X., & Gao, F. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15383 · Cited by 22 · see citing works

Loss of Pericytes in Radiation Necrosis after Glioblastoma Treatments

Lee, S., Seo, Y., Bae, J., Chu, K., Kim, J. W., Choi, S. H., Kim, T. M., Kim, I. H., Park, S., & Park, C. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0695-z · Cited by 23 · see citing works

Mural Cells: Potential Therapeutic Targets to Bridge Cardiovascular Disease and Neurodegeneration

Lin, A., Peiris, N. J., Dhaliwal, H., Hakim, M., Li, W., Ganesh, S., Ramaswamy, Y., Patel, S., & Misra, A. (2021) · Cells · doi:10.3390/cells10030593 · Cited by 23 · see citing works

The Role of Blood–Brain Barrier Disruption in Epilepsy: Mechanisms and Consequences

Suleymanova, E. M., & Karan, A. A. (2025) · Neurology International · doi:10.3390/neurolint18010001 · Cited by 23 · see citing works

Platelet-derived growth factor signalling in neurovascular function and disease

Li, S. Y., Johnson, R. H., Smyth, L. C. D., & Dragunow, M. (2022) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2022.106187 · Cited by 22 · see citing works

sPDGFRβ and neuroinflammation are associated with AD biomarkers and differ by race: The ASCEND Study

Butts, B., Huang, H., Hu, W. T., Kehoe, P. G., Miners, J. S., Verble, D. D., Zetterberg, H., Zhao, L., Trotti, L. M., Benameur, K., et al. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.13457 · Cited by 20 · see citing works

Soluble Biomarkers of Cerebrovascular Pathologies

Foley, K. E., & Wilcock, D. M. (2024) · Stroke · doi:10.1161/strokeaha.123.044172 · Cited by 21 · see citing works

3K3A-Activated Protein C Protects the Blood-Brain Barrier and Neurons From Accelerated Ischemic Injury Caused by Pericyte Deficiency in Mice

Wang, Y., Kisler, K., Nikolakopoulou, A. M., Fernández, J. A., Griffin, J. H., & Zloković, B. V. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.841916 · Cited by 20 · see citing works

Platelet-derived growth factor-BB and white matter hyperintensity burden in APOE4 carriers

Kapoor, A., & Nation, D. A. (2022) · Cerebral Circulation - Cognition and Behavior · doi:10.1016/j.cccb.2022.100131 · Cited by 19 · see citing works

The rise of pericytes in neurovascular research

Beard, D. J., Brown, L. S., & Sutherland, B. A. (2020) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x20958497 · Cited by 18 · see citing works

Brain mesenchymal stem cells: physiology and pathological implications

Pombero, A., García‐López, R., & Martı́nez, S. (2016) · Development Growth & Differentiation · doi:10.1111/dgd.12296 · Cited by 17 · see citing works

Molecular signature and functional properties of human pluripotent stem cell-derived brain pericytesPreprint

Rust, R., Sagare, A. P., Kisler, K., Kim, Y., Zhang, M., Griffin, C., Wang, Y., Clementel, V. A., Shwartz, A., Fraser, S. E., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.06.26.546577 · Cited by 18 · see citing works

Cerebral Aβ 40 and systemic hypertension

Tayler, H. M., Palmer, J. C., Thomas, T. L., Kehoe, P. G., Paton, J. F. R., & Love, S. (2017) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x17724930 · Cited by 16 · see citing works

Brain Microvascular Pericytes—More than Bystanders in Breast Cancer Brain Metastasis

Ippolitov, D., Arreza, L., Munir, M. N., & Hombach‐Klonisch, S. (2022) · Cells · doi:10.3390/cells11081263 · Cited by 17 · see citing works

RNA-Seq Profiling of Neutrophil-Derived Microvesicles in Alzheimer’s Disease Patients Identifies a miRNA Signature That May Impact Blood–Brain Barrier Integrity

Vázquez-Villaseñor, I., Smith, C. I., Thang, Y. J. R., Heath, P. R., Wharton, S. B., Blackburn, D. J., Ridger, V. C., & Simpson, J. E. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23115913 · Cited by 16 · see citing works

Amyloidogenesis and Neurotrophic Dysfunction in Alzheimer’s Disease: Do They have a Common Regulating Pathway?

Jiao, F., Jiang, D., Li, Y., Mei, J., Wang, Q., & Li, X. (2022) · Cells · doi:10.3390/cells11203201 · Cited by 16 · see citing works

Abnormal phosphorylation of protein tyrosine in neurodegenerative diseases

Shu, L., Du, C., & Zuo, Y. (2023) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlad066 · Cited by 17 · see citing works

Gestational and Lactational Iron Deficiency Anemia Impairs Myelination and the Neurovascular Unit in Infant Rats

Isasi, E., Figares, M., Abudara, V., & Olivera‐Bravo, S. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-02798-3 · Cited by 15 · see citing works

Blood biomarkers of vascular dysfunction in small vessel disease progression: Insights from a longitudinal neuroimaging study

García, D. J., Clancy, Ú., Arteaga, C., Hernández, M. D. C. V., Chappell, F. M., Jochems, A. C. C., Cheng, Y., Zhang, J., Thrippleton, M. J., Stringer, M. S., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70152 · Cited by 14 · see citing works

Gradual Not Sudden Change: Multiple Sites of Functional Transition Across the Microvascular Bed

Shaw, K., Boyd, K., Anderle, S., Hammond‐Haley, M., Amin, D., Bonnar, O., & Hall, C. N. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.779823 · Cited by 14 · see citing works

Multiple N-of-1 trials to investigate hypoxia therapy in Parkinson’s disease: study rationale and protocol

Daalen, J. M. J., Meinders, M. J., Giardina, F., Roes, K. C. B., Stunnenberg, B. C., Mathur, S., Ainslie, P. N., Thijssen, D. H. J., & Bloem, B. R. (2022) · BMC Neurology · doi:10.1186/s12883-022-02770-7 · Cited by 14 · see citing works

A Soluble Platelet-Derived Growth Factor Receptor-β Originates via Pre-mRNA Splicing in the Healthy Brain and Is Upregulated during Hypoxia and Aging

Payne, L. B., Abdelazim, H., Hoque, M. M., Barnes, A., Mironovova, Z., Willi, C. E., Darden, J. A., Houk, C., Sedovy, M. W., Johnstone, S. R., et al. (2023) · Biomolecules · doi:10.3390/biom13040711 · Cited by 13 · see citing works

Evidence of Pericyte Damage in a Cognitively Normal Cohort

Haghdel, A., Smith, N. M., Glodzik, L., Li, Y., Wang, X. H., Crowder, T., Zhu, Y., Butler, T., Blennow, K., McIntire, L. B., et al. (2024) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0000000000000623 · Cited by 12 · see citing works

Biofluid biomarkers for Alzheimer’s disease: past, present, and future

An, C., Cai, H., Ren, Z., Fu, X., Quan, S., & Jia, L. (2024) · Medical Review · doi:10.1515/mr-2023-0071 · Cited by 13 · see citing works

High circulating levels of midregional proenkephalin A predict vascular dementia: a population-based prospective study

Holm, H., Nägga, K., Nilsson, E. D., Ricci, F., Melander, O., Hansson, O., Bachus, E., Fedorowski, A., & Magnusson, M. (2020) · Scientific Reports · doi:10.1038/s41598-020-64998-y · Cited by 12 · see citing works

The rise of soluble platelet-derived growth factor receptor β in CSF early after subarachnoid hemorrhage correlates with cerebral vasospasm

Liu, J., Ye, Z.-N., Lv, S., Zhuang, Z., Zhang, X., Zhang, X., Wu, W., Mao, L., Lu, Y., Wu, L., et al. (2018) · Neurological Sciences · doi:10.1007/s10072-018-3329-y · Cited by 12 · see citing works

Blood-brain barrier at the interface of air pollution-associated neurotoxicity and neuroinflammation

Young, T. L., Zychowski, K. E., Denson, J. L., & Campen, M. J. (2018) · Advances in neurotoxicology · doi:10.1016/bs.ant.2018.10.010 · Cited by 11 · see citing works

A meta-analysis of the efficacy of physical exercise interventions on activities of daily living in patients with Alzheimer's disease

Xiao, Y., Fan, Y., & Feng, Z. (2024) · Frontiers in Public Health · doi:10.3389/fpubh.2024.1485807 · Cited by 9 · see citing works

The Provenance, Providence, and Position of Endothelial Cells in Injured Spinal Cord Vascular Pathology

Chopra, M., Bhagwani, A., & Kumar, H. (2022) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-022-01266-9 · Cited by 9 · see citing works

Effects of repeated sleep deprivation on brain pericytes in mice

Wu, Y., Li, P., Bhat, N. R., Fan, H., & Liu, M. (2023) · Scientific Reports · doi:10.1038/s41598-023-40138-0 · Cited by 9 · see citing works

A novel sensitive assay for detection of a biomarker of pericyte injury in cerebrospinal fluid

Sweeney, M. D., Sagare, A. P., Pachicano, M., Harrington, M. G., Joe, E., Chui, H. C., Schneider, L. S. S., Montagne, A., Ringman, J. M., Fagan, A. M., et al. (2020) · Alzheimer s & Dementia · doi:10.1002/alz.12061 · Cited by 74 · see citing works

Regional early and progressive loss of brain pericytes but not vascular smooth muscle cells in adult mice with disrupted platelet-derived growth factor receptor-β signaling

Nikolakopoulou, A. M., Zhao, Z., Montagne, A., & Zlokovic, B. V. (2017) · PLOS ONE · doi:10.1371/journal.pone.0176225 · Cited by 109 · see citing works

PDGF-BB-stimulated brain pericytes release the mediators related to blood-brain barrier dysfunction.

Haruka, S., Takata, F., Egashira, Y., Iwao, T., Yokoya, M., Yasunaga, M., Aridome, N., Fukunaga, Y., & Dohgu, S. (2022) · Proceedings for Annual Meeting of The Japanese Pharmacological Society · doi:10.1254/jpssuppl.95.0_1-p-014

Tracking pericyte dysfunction in Alzheimer’s disease: The emerging role of cerebrospinal fluid platelet-derived growth factor receptor-β

Tsai, S., Liew, H., Wang, M.-J., Hung, W.-T., & Huang, H.-Y. (2026) · Tzu Chi Medical Journal · doi:10.4103/tcmj.tcmj-d-25-00173

A Soluble Platelet-Derived Growth Factor Receptor-β Originates via Pre-mRNA Splicing in the Healthy Brain and Is Upregulated during Hypoxia and Aging

Payne, L. B., Abdelazim, H., Hoque, M. M., Barnes, A., Mironovova, Z., Willi, C. E., Darden, J. A., Houk, C., Sedovy, M. W., Johnstone, S. R., et al. (2023) · Biomolecules · doi:10.3390/biom13040711 · Cited by 13 · see citing works